News Releases

20240320-nerve-regeneration.jpg

Experimental gene therapy for giant axonal neuropathy shows promise in NIH clinical trial

March 20, 2024 — Treatment for rare childhood disease was well tolerated and slowed loss of motor function.
20240320-ga.jpg

Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial

March 20, 2024 — Dry AMD affects part of the eye’s retina that allows for clear central vision.
20240320-covid-heart.jpg

Severe lung infection during COVID-19 can cause damage to the heart

March 20, 2024 — NIH supported study shows that the virus that causes COVID-19 can damage the heart without directly infecting heart tissue.
20240318-endometriosis.jpeg

Repurposed drug shows promise against endometriosis-related pain in animal model

March 18, 2024 — NIH-funded study suggests fenoprofen as a potential therapeutic for disease that affects 1 in 10 U.S. women.
202400318-scan.jpeg

NIH studies find severe symptoms of “Havana Syndrome,” but no evidence of MRI-detectable brain injury or biological abnormalities

March 18, 2024 — Compared to healthy volunteers, affected U.S. government personnel did not exhibit differences that would explain symptoms.
subcortico-cortical.jpg

NIH researchers identify brain connections associated with ADHD in youth

March 13, 2024 — Large study finds atypical interactions between the frontal cortex and information processing centers deep in the brain.
20230412-epstein-barr-virus.jpg

NIH scientists find weak points on Epstein-Barr virus

March 12, 2024 — New details of EBV protein could aid treatment, prevention efforts.
20240312-thc.jpg

Delta-8-THC use reported by 11% of 12th graders in 2023

March 12, 2024 — Use of the psychoactive cannabis product is higher in states without existing delta-8 regulations or cannabis legalization, NIH-funded study finds.
20240312-recover.jpg

NIH opens long COVID trials to evaluate treatments for autonomic nervous system dysfunction

March 12, 2024 — Part of NIH’s RECOVER Initiative, trials will test at least three treatments for symptoms such as fast heart rate, dizziness and fatigue.
20240308-tooth-decay.png

Topical solution halts tooth decay in children

March 8, 2024 — NIH-funded study finds non-invasive application of silver diamine fluoride superior to placebo.

Site Menu

You are here

News & Events

News Releases

20240320-nerve-regeneration.jpg

Experimental gene therapy for giant axonal neuropathy shows promise in NIH clinical trial

20240320-ga.jpg

Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial

20240320-covid-heart.jpg

Severe lung infection during COVID-19 can cause damage to the heart

20240318-endometriosis.jpeg

Repurposed drug shows promise against endometriosis-related pain in animal model

202400318-scan.jpeg

NIH studies find severe symptoms of “Havana Syndrome,” but no evidence of MRI-detectable brain injury or biological abnormalities

subcortico-cortical.jpg

NIH researchers identify brain connections associated with ADHD in youth

20230412-epstein-barr-virus.jpg

NIH scientists find weak points on Epstein-Barr virus

20240312-thc.jpg

Delta-8-THC use reported by 11% of 12th graders in 2023

20240312-recover.jpg

NIH opens long COVID trials to evaluate treatments for autonomic nervous system dysfunction

20240308-tooth-decay.png

Topical solution halts tooth decay in children

Pages

Connect with Us